Search results for: 'detection and response'
- Did you mean
- detection ad response
- Related search terms
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (1509=3753) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,1509) END) FROM DUAL) IS NULL-- wUvH
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
- android ed pacs terminal forecast 2024
-
31 Jul 2017  |  North America  |  Market Research
US Hospital Workforce Management Software Market, Forecast to 2020
Healthcare Shifts to a Data-Driven Strategic Approach to Managing Labor
Hospitals often face an intricate balancing act in delivering the right clinical, operational and administrative mix of employees to achieve multiple goals and needs of the enterprise. Connecting all the dots for proactive and on-budget workforce strategic planning is almost impossible to achieve with paper-based systems given the increasing amount...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Jul 2026  |  Global  |  Market Research
Healthcare Cybersecurity, Global, 2026–2031
Patient-Safety Resilience is Driving Transformational Growth in Connected Healthcare Ecosystems
The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patient-facing applications, and interoperable care eco...
$4,950.00 -
21 Sep 2026  |  Europe  |  Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
From Innovation to Execution: Scaling AI, Data, and Workflows in Healthcare
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and discussions with industry leaders, a consistent me...
$2,450.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
08 Nov 2018  |  North America  |  Market Research
US Population Health Management Market, Forecast to 2022
How PHM 2.0 Symbolizes Precision Health
Frost & Sullivan announces exciting new research from its Transformational Health program touching on some of the most important issues in healthcare now and in the future. This Frost & Sullivan research service presents a comprehensive analysis of the market potential and dynamics of the population health management (PHM) market in the United S...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Mar 2019  |  North America  |  Market Research
US Care Coordination Software Market, Forecast to 2023
Optimizing Value-based Reimbursement with Coordinated Care Approaches
The care coordination workflow aims to optimize the entire value chain of patient care. The objective of this research service is to present a comprehensive analysis of the US care coordination software market, with respect to market potential and key market dynamics at play in the next 5 years. The regional scope of the analysis is the United Stat...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
23 Dec 2020  |  North America  |  Frost Radar
Frost Radar™: US Healthcare Cybersecurity Market, 2020
A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines
The US healthcare cybersecurity market is poised for aggressive growth after the COVID-19 pandemic ends. The impending challenges related to the top 5 cyber threats (phishing attacks, credential harvesting, ransomware, social engineering attacks, and information theft or loss) will drive a higher spend on progressive cybersecurity solutions across...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Jul 2021  |  North America  |  Market Research
United States Healthcare Consumerism Growth Opportunities
The Quantified Self Consumer Behavior and Innovative Business Models Create Future Growth Potential
This research service examines the future of healthcare consumerism in the United States in terms of changing patient demographics and demands, technological advancements, digital health, shift in consumer behavior to non-traditional healthcare settings, and innovative healthcare business models. Healthcare consumerism is on the rise as individual...
$2,450.00
Special Price $1,837.50 save 25 %
-
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00